Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Protocols, grant proposals, registered reports (RR1)

Latest Submissions Open for Peer Review

Open peer-review allows users to assign themselves as peer-reviewers. Reviews are expected to be submitted within 2 weeks. Submitting authors have to opt-in to have their submissions openly peer-reviewed (recommended).

Titles/Abstracts of Articles Currently Open for Review:

  • Risk factors related to the incidence of stroke-associated pneumonia in adults: a scoping review protocol

    Date Submitted: Dec 26, 2025
    Open Peer Review Period: Dec 29, 2025 - Feb 23, 2026

    Background: Cerebrovascular diseases remain a major public health challenge, with stroke ranking among the leading causes of mortality worldwide. Among post-stroke complications, pneumonia stands out due to its high prevalence and its negative impact on clinical outcomes, including prolonged hospital stay and increased mortality. Despite its importance, the available evidence on risk factors associated with stroke-related pneumonia is characterized by heterogeneous approaches, which justifies the need for a structured and comprehensive synthesis. Objective: To map the risk factors related to the incidence of stroke-associated pneumonia in adults hospitalized after stroke. Methods: This scoping review protocol was developed in accordance with the Joanna Briggs Institute Reviewer’s Manual and the PRISMA-ScR extension. Searches will be conducted in indexed databases (PubMed, Embase, Scopus, Cochrane Library, Web of Science, and the Virtual Health Library) and grey literature sources (Google Scholar, CAPES Theses and Dissertations Catalog, Brazilian Digital Library of Theses and Dissertations, ProQuest, SciELO Preprints, medRxiv, ClinicalTrials.gov, and the Brazilian Registry of Clinical Trials), as well as documents from the World Health Organization, Pan American Health Organization, Centers for Disease Control and Prevention, European Stroke Organisation, and the Brazilian Ministry of Health. Qualitative, quantitative, and mixed-methods studies, including observational and experimental designs, will be considered, with no restrictions on language or publication date, provided that full-text and free access are available. Study selection will follow three phases using Mendeley® and Rayyan QCRI®. Results: The protocol has been developed and registered. Preliminary searches were conducted in August 2025 in PubMed, Embase, and the Cochrane Library, allowing consolidation of the search strategies and planning of the subsequent stages of the review. Conclusions: This scoping review will provide a comprehensive mapping of the available evidence on risk factors associated with stroke-related pneumonia, supporting a better understanding of the phenomenon and informing future research, clinical practice, and preventive strategies in hospital settings.

  • Background: The effectiveness of ST-elevation myocardial infarction (STEMI) treatment is highly time-dependent, and the information barrier between prehospital and in-hospital settings remains a key factor leading to treatment delays. Existing digital coordination tools either have a single function or lack long-term real-world evidence support, making it difficult to meet clinical needs. This study adopts a self-developed prehospital chest pain alert app (hereafter referred to as the App) by Fengxian District Medical Emergency Center. Mediated through a WeChat-based chest pain center group, the App enables prehospital information synchronization, real-time alerts, multidisciplinary coordination, and feedback on treatment outcome parameters to form a closed-loop communication model, providing a solution to break the information barrier. Objective: To evaluate the impact of the App-mediated prehospital-in-hospital coordination model on treatment delays (e.g., time from first ECG to catheterization laboratory preactivation, door-to-wire time) and clinical outcomes (e.g., 30-day major adverse cardiovascular events, 1-year and 4-year all-cause mortality) in STEMI patients, and to assess its generalizability in high-risk subgroups. Methods: This is a single-center retrospective cohort study. STEMI patients admitted to Fengxian District Central Hospital from January 1, 2019, to December 31, 2024, will be enrolled and categorized into three groups: baseline group (January 1, 2019-December 31, 2020, without App use), intervention group (January 1, 2021-December 31, 2024, with App-mediated coordination), and concurrent control group (STEMI patients who came to the hospital independently without calling an ambulance or were transported by ambulance but not reported via the App during the same period). The primary outcome is door-to-wire time (D2W). Secondary outcomes include other treatment delay indicators, clinical prognosis, and App operational efficiency. We will use propensity score matching (PSM) to control for baseline confounding, segmented linear regression to analyze intervention trend effects, and subgroup analysis to assess generalizability in high-risk populations. Results: This study is based on four-year real-world data from the Department of Cardiology and STEMI database of Fengxian District Central Hospital. Baseline data and intervention-related data are derived from the hospital’s electronic medical record system and App backend logs. A total sample size of ≥944 is expected. Data extraction and statistical analysis are scheduled from January to April 2026. Results will focus on the App-mediated model’s effect on reducing treatment delays and improving clinical outcomes. Conclusions: Using four-year real-world data combined with PSM and interrupted time series analysis, this study will provide high-quality evidence for the App-mediated coordination model, which is expected to optimize the regional STEMI care system and offer references for the application of digital health technologies in acute coronary syndrome treatment. Clinical Trial: Planned registration; https://www.chictr.org.cn/

  • Co-design of a physical activity maintenance intervention for people with stroke: a study protocol

    Date Submitted: Dec 18, 2025
    Open Peer Review Period: Dec 19, 2025 - Feb 13, 2026

    Background: Stroke is a global health problem that often causes physical disability and mental health issues in the survivor. Whilst physical activity improves patient outcomes post-stroke, it can be challenging to maintain. Barriers to maintaining physical activity post-stroke include setting of physical activity (PA), motivation, and impairments from the stroke. There is often a desire to maintain physical activity after stroke, but effective interventions are currently limited. Objective: The aim of this study is to co-produce an intervention to support long term PA maintenance for adults with stroke in Northern Ireland. The objectives of this study are as follows: 1. Understand the perspectives of key stakeholders on the components, structure, and content of an intervention to support PA maintenance ensuring the intervention is relevant, acceptable, and feasible for all stakeholders. 2. Co-production and refine a prototype intervention using an iterative process, actively involving stakeholders in the development and customisation of the intervention to meet their specific needs and preferences. Methods: A mixed methods study will be conducted consisting of three stages informed by the DECIPHer co-production framework. Stage 1 will include a scoping review on PA maintenance in survivors of stroke and stakeholder consultation via focus groups to gain understanding from their perspective of PA. Survivors of stroke and their carers, care coordinators and physiotherapists will be recruited from ongoing Post Rehabilitation Enablement Programme (PREP) classes. Additional healthcare professionals with experience in physical activity and stroke will also be recruited via relevant organisations. Individuals who complete stage 1 focus groups will be invited to take part in stage 2 co-design workshops to develop a physical activity maintenance programme for participants post-PREP. Stage 3 will involve expert review of the co-production programme by members of the Project Advisory Board via a questionnaire survey. Results: Qualitative data will undergo reflexive thematic analysis from data collected in stage 1 and 2. Data from the scoping review will help shape the questions for the focus groups and data from the focus groups will help inform questions for the three workshops. All stages will involve the stakeholders to gain feedback and suggestions for the next wave. Conclusions: This study provides necessary information in regards to PA amongst survivors of stroke once they stop community rehabilitation. To our knowledge, there is no further support for the survivors to help maintain their PA levels once they finish the 6-12 week community programme. Engaging with survivors of stroke and their carers, PREP staff, and other exercise professionals will help shape the beginning stages of this study. Upcoming results from the pilot study will provide vital information on how to help PA maintenance in this population. Clinical Trial: The study is registered with clinicalTrials.gov - due to restriction in government funding we are awaiting the trial registration number.

  • Prediction model for frailty in people living with HIV: a protocol for a systematic review and meta-analysis

    Date Submitted: Dec 18, 2025
    Open Peer Review Period: Dec 19, 2025 - Feb 13, 2026

    Background: With the advent of antiretroviral therapy, the life expectancy of people living with HIV (PLWH) has increased significantly, leading to a growing prevalence of frailty and its associated adverse outcomes. However, frailty prediction models developed for the general older population may not apply to PLWH due to their distinct immunologic, inflammatory, and comorbidity profiles. To date, a systematic evaluation of existing frailty prediction models specifically for PLWH is lacking. Objective: Ethical approval has been granted by the Ethics Committee of Beijing Ditan Hospital, Capital Medical University (DTEC-KY2025-088-01). Findings from this study will be disseminated through publication in peer-reviewed academic journals. Methods: With the advent of antiretroviral therapy, the life expectancy of people living with HIV (PLWH) has increased significantly, leading to a growing prevalence of frailty and its associated adverse outcomes. However, frailty prediction models developed for the general older population may not apply to PLWH due to their distinct immunologic, inflammatory, and comorbidity profiles. To date, a systematic evaluation of existing frailty prediction models specifically for PLWH is lacking. Results: Ethical approval has been granted by the Ethics Committee of Beijing Ditan Hospital, Capital Medical University (DTEC-KY2025-088-01). Findings from this study will be disseminated through publication in peer-reviewed academic journals. Conclusions: Research will be located by searching electronic databases, including PubMed, CINAHL, Web of Science, and Embase. Two independent reviewers will conduct the screening of titles and abstracts, evaluate full texts, and extract data. The extraction process will adhere to the CHARMS checklist and the TRIPOD statement. A systematic evaluation of the included studies will be performed to assess their risk of bias and applicability, utilizing the PROBAST tool. If appropriate, meta-analyses will be employed to synthesize quantitative data related to the predictive performance of these models. Clinical Trial: PROSPERO registration number CRD 1076202

  • Background: Cryptosporidium is a protozoan parasite of global importance that causes diarrheal disease in both humans and animals. In Southeast Asia, ecological diversity, agricultural expansion, and uneven infrastructure create a complex landscape for disease transmission. Although numerous studies exist, no comprehensive review has examined environmental, foodborne, and socioeconomic factors through an integrated One Health lens. Objective: To describe the methodology for a scoping review that maps research on Cryptosporidium in Southeast Asia, focusing on prevalence, diagnostic approaches, and transmission determinants across human, animal, and environmental domains. Methods: The review follows Arksey and O’Malley’s framework, refined by Levac et al. and the Joanna Briggs Institute. Five databases were searched using broad organism- and geography-based terms. Screening and data extraction were conducted in Covidence with predefined criteria. Descriptive synthesis and thematic mapping will be performed in RStudio. The protocol is registered on the Open Science Framework. Results: Early observations indicate geographic gaps and limited application of One Health frameworks constraining understanding of Cryptosporidium ecology in Southeast Asia. Conclusions: This review will identify research gaps, variations in diagnostic methods, and opportunities for integrated surveillance and control. Findings will inform future research priorities and support multidisciplinary approaches under the One Health framework.

  • Background: Close contacts of individuals with active pulmonary tuberculosis (TB) face an elevated risk of TB acquisition, necessitating systematic screening for latent tuberculosis infection (LTBI) and subsequent TB preventive treatment (TPT). Major TPT regimens require ≥3 months of drug exposure and demonstrate suboptimal safety profiles, significantly compromising treatment completion rates. The development of shorter, safer chemoprophylaxis strategies therefore represents a critical need in global TB control. Among close contacts, school-aged children and adolescents constitute the most vulnerable demographic subgroup, warranting prioritized intervention efforts. Objective: To evaluate the non-inferiority of a novel, ultra-short regimen (1H3P3: one-month isoniazid plus rifapentine three times weekly) compared to the standard 3-month daily isoniazid plus rifampicin (3HR) regimen for TPT among LTBI cases identified from school-based TB close contacts. Methods: We are conducting an investigator-initialed prospective, multicenter, open-label, non-inferiority, cluster randomized controlled clinical trial under the national TB control program in China. Close contacts of school pulmonary TB index cases regardless of diagnostic types are actively screened with symptoms, interferon-gamma release assay (IGRA) test, chest imaging, and sputum molecular diagnostic testing to detect TB infection and exclude active TB. Eligible LTBI cases will be randomized at a 1:1 cluster ratio to receive either a standard 3HR regimen (3-month daily isoniazid plus rifampicin) or a novel 1H3P3 ultra-short regimen (one-month isoniazid plus rifapentine three times a week) for TPT with subsequent follow-up to two years for disease progression. The primary composite endpoint includes microbiologically confirmed TB (sputum culture or molecular diagnostic testing) or clinically diagnosed TB. With 80% power to detect non-inferiority (20% margin), the study requires 1,760 participants per arm, accounting for cluster design effects. Results: [As this is a study protocol, results are not yet available. Data collection is in progress。] Conclusions: Shortening treatment duration is a key to improve adherence to TPT, thus achieving optimal protective efficacy. This trial evaluates a promising ultra-short, well-tolerated TPT regimen with an active control. Cluster randomization was adopted to reduce interference in school-setting, potential limitations include implementation challenges by enlarged sample size, complicated cluster assignment and limited generalizability by school-based population. If successful, this ultra-short, well-tolerated regimen could optimize TPT delivery, particularly in congregate settings. Integrating with active screening, our findings may inform scalable TB control strategies, advancing progress toward global TB elimination goals. Clinical Trial: ClinicalTrials.gov NCT06022146. https://clinicaltrials.gov/study/NCT06022146

  • Background: A significant proportion of patients with major depressive disorder do not achieve remission after two antidepressant trials and are considered to suffer from Treatment-Resistant Depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for TRD. However, relapse rates among remitters within the first year post-treatment are significant, and there are no validated markers of relapse. Wearable devices have shown positive results for longitudinal monitoring of health metrics and may be a promising tool for an early detection of relapse following rTMS treatment. Objective: To evaluate the feasibility of a wearable device (Oura ring) to monitor individuals receiving rTMS treatment for depression and its utility to detect early signs of depressive relapse in a 6-month follow-up period. Methods: This single-arm pilot study will recruit 20 outpatients with a major depressive episode receiving rTMS at St. Joseph’s Healthcare Hamilton, Ontario, Canada. Participants will be required to wear an Oura ring throughout the treatment course and during the six-month follow up. Clinical assessments, including Montgomery-Åsberg Depression Rating Scale (MADRS), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Insomnia Severity Index (ISI), and World Health Organization-Five Well-Being Index (WHO-5), will be collected at baseline, treatment end, and 3- and 6-month follow-ups, alongside bi-weekly PHQ-9 and GAD-7 scores. The primary outcomes are feasibility metrics (i.e., recruitment, adherence, retention, missing data, usability). Secondary outcomes will include the utility of wearable-based data for predicting relapse. Results: The study was funded in December 2025, and data collection will start following Ethics Approval. Conclusions: This study will provide initial evidence on the feasibility and utility of a wearable-based digital phenotyping in individuals receiving rTMS for TRD. Our findings will inform the design of future large-scale studies aimed at wearable-supported relapse prevention and precision monitoring in depression care.

  • Effects of artificial intelligence on nursing education: A study protocol for systematic review and meta-analysis

    Date Submitted: Dec 12, 2025
    Open Peer Review Period: Dec 16, 2025 - Feb 10, 2026

    Background: Artificial intelligence (AI) demonstrates considerable potential in nursing education. However, its specific effects on knowledge acquisition, practical skills, satisfaction, competence, and confidence remain inadequately characterized. Objective: This study aims to assess the effects of AI on nursing students’ education. Methods: We will follow the preferred reporting items for systematic review and meta-analysis protocol guidelines. Systematic literature searches will be conducted across six electronic databases, namely, PubMed, Web of Science, EMBASE, CINAHL, EBSCO, and the Cochrane Library. The inclusion criteria follow the PICOS framework, incorporating nursing students from academic institutions and clinical internship settings. This review examines studies comparing AI-based educational interventions with traditional teaching methodologies. The outcomes encompass (1) knowledge level, (2) practical ability, (3) satisfaction, (4) competence, and (5) confidence. Eligible study designs include randomized controlled trials (RCTs) and quasi-experimental studies. The search timeline is from the inception of each database to February 2026, with no language restriction. Two independent reviewers will screen studies and extract data. Any disputes will be resolved through discussion. Unresolved disputes will be decided by consulting the third author. For the risk of bias assessment, the Cochrane risk-of-bias (ROB) tool for RCTs and the risk of bias in non-randomized studies of intervention (ROBINS-I) tool will be used. Moreover, RevMan 5.3 is used for meta-analysis. Results: / Conclusions: / Clinical Trial: PROSPERO registration number: CRD420251170836.

  • Background: Mechanically ventilated critically ill patients face significant risks from prolonged immobilization, including ICU-acquired weakness and prolonged recovery. Early mobilization is increasingly advocated to mitigate these risks. While existing studies suggest early mobilization may reduce ventilator days and ICU length of stay, its impact on mortality remains unclear due to conflicting results and methodological limitations, particularly insufficient statistical power and the lack of conclusive evidence. This uncertainty necessitates a more robust synthesis incorporating Trial Sequential Analysis (TSA) to evaluate the reliability and conclusiveness of current evidence regarding early mobilization's efficacy. Objective: evaluate the reliability and conclusiveness of current evidence regarding early mobilization's efficacy. Methods: Randomized controlled trials (RCTs) that compare early mobilization and usual care in mechanically ventilated critically ill patients will be included. Literature searches will be conducted in PubMed, Web of Science, Embase, and Cochrane Library. Two reviewers will independently perform the processes of literature retrieval, screening, data extraction, and assessment of risk of bias. Risk of bias in included studies will be evaluated using Revised Cochrane risk-of-bias tool (ROB 2) for RCTs. Review Manager (RevMan) will be used for data pooling. Subgroup analysis, trial sequential analysis (TSA), and sensitivity analysis will be conducted. Results: Not applicable Conclusions: Not applicable

  • Service Robots for Work Support of Health Personnel in Long-term Care: Protocol for a Scoping Review

    Date Submitted: Dec 12, 2025
    Open Peer Review Period: Dec 16, 2025 - Feb 10, 2026

    Background: Demographic shifts are increasing the global demand for long-term care services, coinciding with a worldwide shortage of healthcare personnel. Service robots, designed to perform tasks in both professional and personal use, are perceived as a potential solution to alleviate healthcare personnel’s workload and enhance the quality of care. However, the existing literature is fragmented and heterogeneous, with a limited emphasis on the role of service robots in supporting residents rather than healthcare personnel. Furthermore, there is a lack of consistent definitions of service robotic technologies and a scarcity of studies on implementation models and frameworks. Objective: This scoping review aims to map and synthesize evidence regarding the implementation of service robots as work support for healthcare personnel in long-term care settings. Methods: A comprehensive three-step search will be conducted in Embase, MEDLINE, APA PsycInfo, CENTRAL, Scopus, and CINAHL, along with grey literature databases and institutional repositories. Eligible sources encompass empirical studies and grey literature involving service robots, healthcare personnel, residents aged 65 years or older, and stakeholders such as informal caregivers within institutional long-term care. Exclusions apply to studies on home care, medical or industrial robots, and non-robotic technologies. Data will be extracted and analysed using the JBI methodology, with findings presented in tables, diagrams, and narrative summaries to identify gaps and inform future research and implementation strategies. Results: This protocol was developed in October 2025 and subsequently registered in November 2025. A comprehensive search strategy was formulated and completely conducted on October 24, 2025. The screening of titles and abstracts was completed in November 2025. The processes of data extraction, analysis, evidence synthesis, and results presentation will be conducted sequentially, with the scoping review expected to be finalized by April 2026. Conclusions: The findings of this proposed scoping review are anticipated to delineate the scope, characteristics, and implementation models of service robots employed to support healthcare personnel in executing routine tasks for older adults in long-term care settings. Furthermore, the review is expected to identify research gaps within the existing literature, elucidate key concepts, and establish a foundation for future empirical investigations into implementation strategies for service robots in healthcare. Clinical Trial: This protocol was registered in Open Science Framework on November 7, 2025. Register: https://osf.io/t5p2x

  • Background: Background: Falls are a critical global public health issue for community-dwelling older adults, with delayed emergency response being a leading contributor to pre-hospital mortality[1]. The World Health Organization (WHO) emphasizes that as populations age, the disease burden of fall-related injuries in older adults continues to grow—yet existing intervention tools often lack adaptability to the unique needs of this group [1]. A retrospective analysis of electronic medical records from Shanghai’s Fengxian District Medical Emergency Center (June 1, 2020–May 15, 2025) revealed striking local trends: 72.37% of pre-hospital deaths among adults aged ≥60 years stemmed from delayed rescue following accidents or acute illness, with falls accounting for 89.2% (2111/2366) of these cases. Notably, adults aged 70–90 years formed the core high-risk cohort, representing 65.89% of fall-related deaths without resuscitation potential; key high-risk ages included 75 years (99 cases), 70 years (93 cases), 90 years (92 cases), and 80 years (90 cases). Industry interviews with smart elderly care technology providers, combined with findings from Moore K et al.’s [3] qualitative systematic review, confirm critical gaps in current products: overly complex operation, limited battery life, and inadequate integration with local Emergency Medical Services (EMS). These limitations underscore an urgent need for a tailored fall alert solution. Objective: Objectives: Primary objective: To assess the feasibility and operational suitability of a smartwatch-based emergency response system for community-dwelling older adults aged 70–90 years, with specific focus on system reliability and its potential to reduce fall-related rescue delays. Secondary objectives: (1) Validate key feasibility metrics, including a device wear compliance rate ≥75% (defined as daily wear time ≥12 hours), a false alarm rate ≤10% (confirmed via EMS and caregiver verification), and a System Usability Scale (SUS) score ≥70 [11]; (2) Evaluate the system’s ability to shorten emergency response time to ≤15 minutes (from alert trigger to EMS on-site arrival) and document at least one clinically confirmed timely rescue during the study period. Methods: Methods/Design: This feasibility study is centered on a purpose-built fall alert system, comprising a simplified smartwatch, a caregiver/community management application, and a cloud-based EMS integration platform. System design prioritizes localization: bilingual audio prompts (Shanghai dialect and Mandarin), magnetic charging for ease of use, and three large physical buttons to minimize operational barriers. We plan to recruit 300 households (each with one community-dwelling older adult aged 70–90 years) from Fengxian District. Sample size was determined based on Kokorelias KM et al.’s [4] scoping review, which recommends 200–500 participants for wearable technology feasibility studies, with a 10% attrition rate factored in to ensure statistical robustness (95% confidence level, 5% margin of error). Data will be collected over 12 months using three complementary sources: device-generated metrics, EMS rescue documentation, and structured user feedback questionnaires. Statistical analysis will be performed in SPSS 26.0 [14], with qualitative data analyzed via thematic coding. Results: Expected Results: Study initiation is contingent on securing government support and ethical approval. The study will proceed with a 6-month recruitment phase followed by 12 months of data collection, preceded by a system pre-test to refine usability. We anticipate meeting all preset feasibility benchmarks (wear compliance, false alarm rate, usability score, recruitment rate) and effectiveness targets (average response time, timely rescues). Age-stratified analyses (70–79 years vs. 80–90 years) will further clarify the system’s adaptability across the high-risk spectrum. Conclusions: Conclusion: This feasibility study will validate the system’s performance, usability, and real-world applicability, addressing critical shortcomings in existing fall alert technologies. If proven feasible, the system will provide a foundation for large-scale deployment, reduce fall-related pre-hospital mortality by mitigating rescue delays, and offer a scalable model for public health interventions in aging communities. Clinical Trial: Not applicable

  • Background: Background: Evidence-based Clinical Practice Guidelines (CPGs) are fundamental to translating research into practice but are often hindered by their complex, text-heavy format, limiting accessibility for both clinicians and patients. Narrative Medicine offers a pathway to humanize evidence through storytelling, and short-video platforms present an unprecedented opportunity for mass dissemination. However, a systematic, theory-informed framework for converting text-based CPGs into narrative-based short videos is currently lacking. Objective: Objective: This protocol aims to develop and pilot-test a standardized "CPG-to-Video" framework that integrates Narrative Medicine principles to create engaging, accurate, and patient-centered short videos from CPGs. Methods: Methods: We will conduct the project using the following steps: (1) Needs assessment (systematic literature review to identify the necessity of developing a comprehensive framework for CPG-to-video translation), (2) Establishing international working groups (coordination team, evidence support group, and consensus group), (3) Conducting literature reviews and qualitative research to formulate an initial draft framework, (4) A consensus process including an expert survey and a consensus meeting, (5) Formulating and releasing the final framework, and (6) Testing the framework (collecting feedback through educating health professionals and applying the framework in practice to evaluate and improve it). Results: Expected Outcomes: The primary outcome is a replicable "CPG-to-Video" framework. Conclusions: Conclusion: This protocol provides a methodological foundation for leveraging Narrative Medicine and short-video platforms to bridge the evidence-practice gap, potentially enhancing guideline understanding, adherence, and patient engagement.

  • Background: Child maltreatment is a major public health concern with long-term neurobiological and psychosocial consequences. The detection and reporting of suspected cases often remain fragmented, with significant variability across services and the absence of a unified surveillance system. Pediatricians also lack adequate digital tools and specialized training to support timely recognition and documentation. Although international evidence shows that integrated digital registries and structured educational programs enhance early identification and interprofessional coordination, no comparable model has yet been systematically implemented in Italy. The Sentinel project was developed to address these gaps through the combined introduction of a REDCap-based digital registry and a structured training program for pediatric healthcare professionals. Objective: This study aims to evaluate the usability, feasibility, and preliminary impact of an integrated surveillance and training system designed to improve the early detection, documentation, and reporting of suspected child maltreatment by pediatricians and healthcare professionals. Methods: This observational, exploratory, monocentric study will span 24 months and involve hospital and community pediatricians who voluntarily enroll and provide informed consent. The project includes two interconnected components: (1) the development and implementation of a secure, anonymized digital registry for standardized data collection on suspected maltreatment, and (2) a theoretical–practical training program delivered through lectures, e-learning modules, webinars, and hands-on sessions. Usability will be assessed using the System Usability Scale (SUS). Training effectiveness will be evaluated through pre–post knowledge tests, competency assessments, and qualitative feedback. Statistical analyses will include descriptive statistics, paired-sample tests, Poisson or negative binomial regression for changes in reporting rates, and multivariable models to identify predictors of training outcomes and registry usability. Results: We expect high usability of the digital registry, with mean SUS scores exceeding 80. Reporting rates of suspected maltreatment are anticipated to increase markedly following implementation. Training is expected to result in substantial improvements in knowledge, competencies, and satisfaction, enhancing professionals’ capacity to recognize and manage suspected maltreatment. The integrated system is expected to improve reporting completeness, timeliness, and interprofessional coordination. Conclusions: The Sentinel project is expected to validate an innovative, scalable model that integrates digital surveillance with structured training to enhance early detection and management of child maltreatment. By standardizing data collection, strengthening professional competencies, and fostering collaboration across hospital and community settings, the project aims to support the development of a regional or national observatory and promote an evidence-based, system-wide cultural shift in child protection. Clinical Trial: ClinicalTrials.gov Identifier: NCT07250074

  • Background: Liver cirrhosis leads to an impaired liver function with reduced metabolisation capacity which affects the pharmacokinetics of several drugs requiring dose adjustments. Although limited literature provides guidance on appropriate administration of drugs in cirrhosis, no guidelines currently existfor dose selection or adjustment. Objective: The objective of this study is to provide guidance on the selection, dosing and appropriate use of drugs in patients with liver cirrhosis and to evaluate the clinical application of these recommendations. Methods: Three steps are planned to establish dose recommendations for patients with liver cirrhosis: (1) A systematic literature search will be conducted to identify specific recommendations for drug selection and dosing in cirrhosis and assessed for reporting quality and evidence level. Subsequently, the resulting recommendations will be undergo an internal pre-assessment procedure for relevance of the covered drugs with regard to availability, the clinical impact of adverse drug reactions, the frequency of use and the expected benefit of dose adjustment. (2) A modified Delphi procedure will be conducted to (a) analyze the clinical handling of the identified drugs by experts in clinical practice in a first round and (b) harmonize differing dose recommendations in a second round. (3) Finally, the adopted dose recommendations will be implemented in a clinical study involving patients with liver cirrhosis to analyze their impact on the patients´ safety. Results: The study has been registered in the German Registry of Clinical Trials (DRKS00033779), and the planned clinical validation phase is currently underway. Conclusions: This protocol outlines a structured approach combining a systematic literature review of specific dose recommendations in patients with cirrhosis integrating a quality assessment to ensure the inclusion of only high-quality evidence, expert opinions by a Delphi consensus aligning differing recommendations and a clinical validation to support safer drug therapy in patients with liver cirrhosis. Clinical Trial: This study was registered in the German Registry of Clinical Trials (DRKS) on 2024-12-27 with code number DRKS00033779 (https://www.drks.de/search/de/trial/DRKS00033779 ).

  • The use of Silver Fluoride for oral health and wellbeing in aged care residents: Protocol for a Cluster Randomised Controlled Trial

    Date Submitted: Nov 27, 2025
    Open Peer Review Period: Dec 8, 2025 - Feb 2, 2026

    Background: There are specific challenges in identifying and delivering effective treatments which can protect and improve oral health in residential aged care facilities (RACFs). This is especially the case in those living in regional and rural areas. Given the consequences of poor oral health for older people living in RACFs, there is an urgent need for high-quality evidence on oral health interventions that are appropriate to context and need, accessible, and cost-effective for aged care residents. Applying aqueous forms of silver fluoride (AgF) can be effective and suitable for improving this population’s oral health and wellbeing. Objective: This paper outlines a research protocol which aims to test the effectiveness of an AgF intervention package in reducing tooth sensitivity, tooth pain, arresting caries, and improving oral health and wellbeing in older adults living in regional and rural RACFs. Methods: This study protocol describes a cluster randomised controlled trial with two parallel arms. The control arm will receive delayed intervention after 3-months. This approach allows for all participants to receive an oral examination and access to AgF treatment by the end of the study. Study sites include RACFs in public and private sectors across rural and regional Queensland and New South Wales, Australia. Oral assessments will be undertaken for RACF residents who provided consent, with at least one natural tooth. Teeth will be assessed for eligibility to receive AgF treatment. Outcomes at the 3-month follow-up will be collected through survey and clinical examination and include tooth sensitivity and pain, dental caries and oral health-related quality of life. Results: This clinical study is part of an overarching project funded by the MRFF Dementia Ageing and Aged Care Grant #2024439. Data collection commenced in May 2025 for the cluster randomized controlled trial and is anticipated to continue until March 2026. Conclusions: This research protocol will provide a rigorous test of the efficacy of a minimally invasive intervention package of AgF to improve the oral health and wellbeing of older adults in RACFs. Clinical Trial: This clinical trial has been registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12625000072415: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12625000072415

  • Background: Work ability decline among working-age adults is a major public health concern, requiring effective prevention strategies. While conventional in-person prevention programs show benefits, fully digital formats offer scalability and accessibility advantages. However, evidence on the effectiveness, sustainability, and behavioral mechanisms of digital-only prevention programs remains limited. Objective: This study aims to evaluate the effectiveness and sustainability of a fully digital multicomponent prevention program on work ability, health, and health behaviors, and to examine behavioral mechanisms through ecological momentary assessment (EMA). Methods: This quasi-experimental mixed-methods evaluation will compare three intervention formats: fully digital prevention program, digitally supported program (N=147), and conventional in-person program (N=98). Participants are working-age adults (18-65 years) eligible for German pension insurance prevention programs. The digital intervention consists of a 6-months app-based program including coaching sessions, webinars, and health modules targeting physical activity, stress management, and nutrition. Assessments occur at five timepoints: baseline (T0), mid-intervention (T1, 3 weeks), post-intervention (T2, 6 weeks), and follow-ups at 3 months (T3) and 6 months (T4). Primary outcomes include the Work Ability Index and SF-12 Physical and Mental Component Summaries. Secondary outcomes include physical activity, motivation, stress, and eating behavior. Daily EMA captures intention, habit, affect, and perceived behavioral control. Data will be analyzed using repeated measures ANOVA/ANCOVA for effectiveness, multilevel modeling for EMA data, and thematic analysis for qualitative interviews. Results: Data collection for the fully digital prevention program is ongoing, while comparative baseline data from the digitally supported (N=147) and conventional in-person (N=98) programs are already available. Analyses will include repeated-measures ANOVA and ANCOVA to assess changes in work ability, physical and mental health, and related behaviors. EMA data will be analyzed using multilevel modeling to examine daily fluctuations in intention, affect, perceived behavioral control, and habit strength, providing insights into behavioral mechanisms, while qualitative interviews will be analyzed using thematic analysis to identify recurring themes related to user experiences, perceived effectiveness, and contextual factors influencing engagement and sustained behavior change. Conclusions: This study will provide evidence on the sustainability of digital prevention effects through 6-month follow-up, address gaps in understanding mechanisms of behavior change through dual process theory tested with real-time EMA data, and contribute comparative effectiveness evidence for digital versus blended versus conventional intervention formats. Clinical Trial: German Clinical Trials Register (DRKS): DRKS00036417 https://www.drks.de/search/de

  • Background: Osteoporosis and diabetes are both prevalent chronic diseases. The complex pathophysiological interactions between glucose metabolism and bone health contribute to an elevated osteoporosis risk in diabetic patients. However, some glucose-lowering medications adversely affect bone metabolism. Herbal formulations have been proposed as complementary interventions, although systematic evidence supporting their use remains limited. Previous studies by our research group indicated that Gushuling (GSL) may improve osteoporotic conditions. Nevertheless, high-quality randomized controlled trials are lacking to clarify the efficacy of GSL for diabetes complicated by osteoporosis. Objective: This study evaluates the effectiveness and safety of GSL in managing patients with both diabetes and osteoporosis. Methods: This prospective, randomized, single-center clinical trial enrolled 60 participants, who were centrally allocated in a 1:1 ratio to receive either Gushuling (GSL) combined with Caltrate D3 Tablets and Alendronate Sodium Tablets, or Caltrate D3 Tablets and Alendronate Sodium Tablets alone. A 24-week treatment period was followed by a final assessment at week 36, which occurred 12 weeks after treatment discontinuation. The primary outcome was bone mass, measured by bone mineral density (BMD). Secondary outcomes included serum levels of Ca, P, ALP, plasma 25-hydroxyvitamin D3 [25(OH)D3], β-CrossLaps (β-CTx), osteoprotegerin (OPG), MiR-135a-5p, Foxo1, and PTGS2, in addition to blood glucose levels. All statistical analyses were conducted using SPSS 28.0, with no interim analysis performed. Results: Data collection will commence in August 2024 and conclude in June 2025, with analysis scheduled to begin in the summer of 2026. Final results are anticipated by the end of 2026.This study provides evidence to advance the clinical understanding of Traditional Chinese Medicine for managing diabetes mellitus complicated by osteoporosis. Conclusions: This trial establishes a methodological framework for evaluating the clinical efficacy, safety, and potential mechanisms of GSL in patients with diabetes and osteoporosis. It also explores expanded avenues for integrating Traditional Chinese Medicine into the comprehensive management of diabetes complicated by osteoporosis. Clinical Trial: This study has been registered with the Chinese Clinical Trial Registry under registration number: ChiCTR2400087572.https://www.chictr.org.cn/searchproj.html.Registration date: July 30, 2024.

  • Background: Inflammatory ocular diseases (IOD) are frequently associated with multi-system autoimmune conditions and can lead to significant visual morbidity, including visual impairment and blindness. Emerging evidence suggests that inflammation contributes to the development of depression and other mental health disorders. Individuals with childhood-onset IOD may be at increased risk of poor well-being and mental health outcomes. However, the prevalence of mental health conditions in this population remains unclear. Objective: To review the evidence regarding the prevalence of mental health conditions amongst children and adults with childhood onset inflammatory ocular disease. Methods: This systematic review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Eligible studies will report mental health disorder prevalence and outcomes in individuals with childhood-onset IOD, regardless of age at assessment of outcome. Studies evaluating interventions or focusing primarily on mental health effects secondary to visual impairment or blindness will be excluded. Searches will be conducted in PubMed, the Cochrane Central Register of Controlled Trials, Embase, Ovid, and PsycArticles. Grey literature will be identified through Google searches. Two researchers will independently screen titles, abstracts, and full texts, extract data, and assess risk of bias using the ROBINS-E tool; disagreements will be resolved by a third reviewer. Data will be synthesised descriptively, with attention to study design, outcome measures, co-occurrence of multi-system disease, and methodological quality. Results: A preliminary scoping search has been completed to estimate the volume of relevant literature. Full searches will begin in November 2025. Data extraction, analysis, and synthesis will follow, using a narrative approach to summarise mental health outcomes across studies. The final review is expected to be completed by August 2026. Conclusions: The findings from this review will help to establish the prevalence of mental health conditions amongst people with childhood onset IOD. The results from this review will support recommendations for further research and policies to ensure the best health outcomes for children. Clinical Trial: PROSPERO registration: CRD420251182619

  • Background: Patient and Public Involvement (PPI) is increasingly recognised for enhancing the relevance, transparency, and impact of research. In autoimmune and inflammatory ocular diseases, including Sjögren's Disease, PPI practices remain inconsistently integrated and underreported. Objective: This scoping review aims to identify and map existing literature on how patients and the public have been involved in research across clinical, translational, and molecular domains related to inflammatory or autoimmune ocular diseases. Methods: Following the Joanna Briggs Institute (JBI) guidance and the PRISMA-ScR checklist, we will conduct a scoping review across three databases (MEDLINE, Embase, CINAHL). Inclusion criteria include studies that explicitly describe PPI in clinical, translational, or preclinical research concerning autoimmune or inflammatory ocular conditions. Two teams of two independent reviewers will screen studies and extract data using a customised extraction tool. Results will be synthesised narratively and visually to describe involvement approaches, settings, impacts and gaps Results: As of [November 2025], database searches are being finalised. Screening and analysis will proceed subsequently. Results will be submitted for peer-reviewed publication, presented at conferences, and shared via patient networks. Conclusions: Findings will support researchers, clinicians, and patient communities in designing more inclusive and impactful autoimmune ocular research. This review will clarify how PPI is currently enacted in ocular autoimmune research and offer recommendations for more meaningful involvement moving forward. Clinical Trial: The protocol for this scoping review is registered with the Open Science Framework (OSF) at https://osf.io/q2k4h/

  • AI- Assisted Chest X-Ray Interpretation in Resource-Limited Settings: LuAna Stepped-Wedge Trial Protocol

    Date Submitted: Nov 28, 2025
    Open Peer Review Period: Dec 1, 2025 - Jan 26, 2026

    Background: Artificial intelligence (AI) has the potential to transform chest radiography (CXR) interpretation by enhancing diagnostic accuracy, identifying subtle findings, reducing errors, and helping prioritize patient care. Although CXR remains a cost-effective and widely used imaging tool, its effectiveness is limited by overlapping anatomy and variability in clinical expertise. Integrating AI can help overcome some of these challenges, especially in resource-constrained settings. However, robust validation in real-world clinical contexts is essential before widespread implementation. This study protocol evaluates whether AI assistance improves general practitioners' ability to detect radiographic findings on CXR in adults with respiratory complaints or undergoing treatment for respiratory diseases, compared to unaided interpretation. Potential benefits include increased diagnostic safety, higher physician confidence, more efficient workflows, and expanded access to expert support in underserved areas. Objective: This project aims to evaluate whether AI assistance enhances physicians’ ability to detect key radiographic abnormalities— including consolidation or pulmonary opacity, pneumothorax, atelectasis, pleural effusion, and cardiomegaly. The primary outcome is the difference in physicians’ diagnostic accuracy (per examination) when assisted by the AI tool compared with usual practice, using the expert radiologist consensus as the reference value. Methods: This is a protocol for a multicenter, stepped-wedge, cluster-randomized clinical trial following the CONSORT-AI extension and SPIRIT-AI guidelines. The intervention involves the diagnostic support Solution for CXR - Lung Analysis (LuAna), an AI-powered chest X-ray interpretation tool developed in partnership with the Brazilian Ministry of Health. Across nine cities in Brazil, clusters will transition monthly from unaided chest X-ray interpretation by general practitioners to AI-assisted interpretation, with performance benchmarked against thoracic radiologists. The stepped-wedge design ensures all clusters receive the intervention, reflecting real-world coordination, enhancing acceptability, improving power, and strengthening causal inference through repeated measures. Diagnostic performance will be compared to a reference standard established by thoracic radiologists. Results: Thirteen research centers across Brazil will participate, covering all five regions and diverse healthcare settings, from primary care to specialized tuberculosis centers. Next steps involve finalizing regulatory approvals and starting participant enrolment once all sites are fully activated. Conclusions: This intervention is expected to enhance clinical decision-making by supporting earlier treatment initiation and more appropriate diagnostic pathways for patients with respiratory symptoms, while maintaining a favorable safety profile and high physician usability. The findings from this trial will provide real-world evidence on the clinical utility of AI-assisted chest radiography. If effective, LuAna may leverage its scalability and equity advantages to become a replicable model for integrating AI into routine imaging workflows worldwide, especially in regions with limited access to specialist care. Clinical Trial: NCT06686251, Registered on 2024-11-13.

  • Background: Symptom clusters are closely related to the decline in patients’ quality of life, increased risk of treatment interruption and poor prognosis. Among patients with ovarian cancer, the manifestation of psychoneurological symptom clusters are particularly prominent, seriously affecting their quality of life and prognosis of the disease. Efficient intervention measures are urgently needed. However, there is still a lack of specific treatment methods for the psychoneurological symptom clusters of ovarian cancer at present. Traditional Chinese medicine shows great potential in improving tumor-related symptom clusters and has unique advantages in overall regulation and comprehensive intervention. Objective: The primary objective of this study is to evaluate the efficacy and safety of the TSZA regimen in alleviating mental and psychological symptoms among ovarian cancer patients. Secondary objectives include assessing its impact on patients’ quality of life and survival outcomes. Furthermore, the study aims to explore the characteristics of the patient population that derives benefit from the TSZA regimen for these symptoms. Methods: A total of 316 ovarian cancer patients aged 18 to 70 with psychoneurological symptom cluster will be included and randomly divided into two parallel groups. Both groups will receive standard treatment for ovarian cancer as the basic treatment. The experimental group will receive the TSZA regimen, that is, Compound Ciwujia Granules (containing Acanthopanax senticosus and Schisandra chinensis) combined with psychological intervention. The control group will receive placebo combined with psychological intervention. The primary outcome measure is the psychoneurological symptom cluster score. Secondary outcome measures included the Pittsburgh Sleep Quality Index (PSQI), the Patient Health Questionnaire -9 (PHQ-9), the Generalized Anxiety Disorder -7 (GAD-7) scale, the revised Piper Fatigue Scale, the EORTC QLQ-C30 Quality of Life Scale, the TCM Syndrome Scale, and the 1-year survival analysis. In addition, this study also set a series of exploratory indicators (including sleep diary, functional magnetic resonance imaging, biomarkers of peripheral blood and tumor tissue, proportion of immune cells, cytokine levels, HPA axis function and immune gene expression analysis) and safety indicators (including vital signs, liver and kidney function and electrocardiogram). The study will be evaluated based on different indicators during the treatment period (baseline and the 1st, 2nd, and 3rd months of enrollment) and the follow-up period (the 6th, 9th, and 12th months of enrollment). Data analysis will be conducted using SPSS 26 software. A p value <0.05 is considered statistically significant. Results: This study is designed to enroll a total of 316 participants. Participant enrollment is set to commence in October 2025, with no recruitment having occurred as of November 2025. The recruitment period will extend until September 2028 or until the target enrollment is met. Data analysis is scheduled for November 2028, with submission of the trial results to a peer-reviewed journal anticipated by May 2029. Conclusions: This study will evaluate the efficacy of the TSZA regimen in managing psychoneurological symptom clusters in ovarian cancer patients, and generate clinical evidence for a new therapeutic option that improves quality of life and alleviates the symptom burden. Clinical Trial: ClinicalTrials.gov NCT07050563; https://clinicaltrials.gov/study/NCT07050563

  • Mental Health Promotion among Black, Caribbean and African immigrants in Canada: a scoping review protocol

    Date Submitted: Nov 27, 2025
    Open Peer Review Period: Nov 28, 2025 - Jan 23, 2026

    Black, Caribbean, and African (BCA) immigrant communities in Canada face systemic inequities that undermine their mental health and limit access to culturally relevant mental health promotion (MHP) strategies. While national policy frameworks increasingly recognize these disparities, there remains a lack of consolidated evidence on existing MHP programs and initiatives developed for, with, or by BCA populations. This scoping review aims to comprehensively map the landscape of MHP strategies, programs, and activities targeting BCA immigrant communities in Canada. It will identify barriers and facilitators influencing implementation and uptake and illuminate gaps in research, policy, and practice. Guided by Arksey and O’Malley’s scoping review framework, the review will draw on six databases Medline (OVID) APA PsychINFO (OVID), EMBASE (OVID), PubMed, CINAHL Plus (EBSCOhost), and Google Scholar, and include grey literature such as community reports and government-funded initiatives. The eligibility criteria focus on English-language sources addressing MHP or mental illness prevention within the Canadian BCA immigrant context. Data will be charted in duplicate and analyzed descriptively then organized using tables and narrative synthesis to highlight thematic trends and opportunities for system transformation. The implications of this review are far-reaching. It will inform evidence-based policy development, support culturally responsive service design, and contribute to equity-driven public health practices. Moreover, it seeks to validate community-led innovations and knowledge systems that are often excluded from formal research. By illuminating both the strengths and silences in current MHP efforts, this study will guide future research and action toward a more inclusive, just, and culturally grounded mental health landscape in Canada.

  • Background: Dyslipidemia is a prevalent lifestyle and metabolic disorder that poses a significant risk for cardiovascular diseases. From the Ayurvedic standpoint, dyslipidemia may be understood as a disorder of fat metabolism. Trikatu, a classical Ayurvedic formulation is scientifically recognized for its role in modulating metabolic processes and enhancing bioavailability. This study was undertaken to assess its role on lipid parameters and markers of metabolism. Objective: To assess the efficacy and safety of Ayurvedic Formulation “Trikatu” for improving lipid parameters in dyslipidemia and to assess the changes in Gut Microbiota Correlates Methods: This study is a prospective, single-centre, randomized, double-blind, placebo-controlled clinical trial involving 120 participants aged 30–60 years with dyslipidemia, including borderline cases with low ASCVD risk and BMI between 18.5 and 29.9 kg/m². Participants will be randomized in a 1:1 ratio to receive either Trikatu (1000 mg) or a matching placebo, administered orally twice daily after food for 12 weeks, along with standardized dietary and lifestyle guidance. A follow-up assessment will be conducted 28 days post-intervention without medication. The primary outcome is the percentage change in fasting plasma triglycerides at 12 weeks. Secondary outcomes include improvements in total cholesterol, HDL, LDL, apolipoproteins, adiponectin, leptin, glycemic and inflammatory markers, gut microbiota profile, blood pressure, insulin resistance (HOMA-IR), and the proportion of participants achieving lipid targets. Drug compliance and any adverse events or drug reactions will be systematically documented. Results: The screening and recruitment process for this trial began on 29 December 2022. The data collection has been completed, and data analysis is scheduled to be initiated. Conclusions: The early intervention in dyslipidemia—especially in borderline cases with low ASCVD risk—is a sustainable strategy to curb the epidemic. Clinical Trial: Clinical Trial Registry of India (CTRI/2022/11/047322) Registered on 15/11/2022.IEC approved on 07.06.2022 with approval number 6-5/CARI/BNG/IEC2020-21/399.

  • Background: Respiratory virus infections, such as Coronavirus Disease 2019 (COVID-19) and influenza, remain significant international public health concerns. While patients with cancer remain the most vulnerable group, they show poor vaccine response in general. Immunologic data in this population are limited and mainly focusing on serologic parameters. However, cellular and especially T cell response seems often to be induced more reliably in those patients than humoral response. Objective: To gain further insights into vaccine-induced immune response, we will analyze the effect of early and late booster vaccination on humoral and cellular responses, with special focus on T cell-induced immune responses. In addition, we aim to investigate factors influencing the humoral and cellular vaccine-induced immune response in pa-tients with hematological and oncological malignancies including state of disease, treatment, and demographic factors. Methods: Humoral immune responses will be assessed by measuring binding and neutralizing antibodies using standardized assays. Cellular immunity will be evaluated using functional assays such as flow cytometry and FluoroSpot, as well as in-depth analyses with additional exploratory assays as appropriate. Immune responses will be correlated with clinical parameters, including disease status, treatment, and demographic factors. Results: As a pilot project, we investigated samples from patients with chronic lymphocytic leukemia (CLL; n=18) before and after influenza vaccination. Analyses of humoral and cellular vaccine-induced immunity are currently ongoing. Conclusions: This study intends to lay a foundation for a structured translational research program of vaccination to aim for best protection from infection by different respiratory patho-gens. Long-term objectives are reaching best possible protection from vaccine-preventable disease with a first focus on influenza infection. In addition, we plan to investigate vaccine-induced immune response to the recently approved respiratory syncytial virus (RSV) vaccine within this platform and possibly further vaccines in the future. Urging questions such as the influence of different targeted therapies on vac-cine immune response will be part of these projects. Clinical Trial: NCT06612515

  • Background: Radial extracorporeal shockwave therapy (rESWT) is effective for treating lower-limb spasticity after stroke. The effect of stimulation numbers in single-session rESWT on improving spasticity in subacute hemiparetic stroke remains unclear. Objective: We aim to clarify the effect of rESWT stimulation numbers on spasticity improvement and assess the feasibility of the evaluation and treatment procedures in subacute stroke. Methods: This single-center, open-label, pilot, randomized controlled trial will enroll 24 individuals with subacute stroke and spasticity, who will be randomly assigned to either the rESWT 3,000- or the 6,000-stimulation group for one treatment at the triceps surae muscle, with stimulation applied at three locations: the medial and lateral heads of the gastrocnemius muscle and the triceps surae muscle–Achilles tendon junction. The stimulation intensity will be the maximum intensity tolerated by the individual (≤3.0 bar), with a 10-Hz fixed frequency. Evaluations will be performed the day before treatment; immediately before and after treatment; at 1 and 8 h post-treatment; and at 1, 2, 3, 5, 7, and 14 days post-treatment. The primary clinical outcome is the intergroup difference in the Modified Ashworth Scale (MAS) score of the triceps surae immediately after treatment. Secondary clinical outcomes include intergroup differences in MAS scores at 1 and 8 h and on days 1, 2, 3, 5, 7, and 14 post-treatment, as well as intragroup differences from baseline to each evaluation point. Additional measures include the range of motion, angle of catch, tendon reflexes, and clonus scores. Safety will be assessed by recording the occurrence of serious and treatment-related adverse events. Results: This study was approved by the Fujita Health University Institutional Review Board on September 26, 2024 (CR24-033) and registered in the Japan Registry of Clinical Trials on October 4, 2024 (jRCTs042240098). Participant enrollment commenced on November 19, 2024 and, as of November 25, 2025, 14 participants have been enrolled. Data analysis has not commenced, and the results will be reported, in 2026, in a separate article. Conclusions: This pilot study provides the first evidence that the number of stimulations delivered in a single session of radial extracorporeal shockwave therapy may influence short-term improvements in spasticity after subacute hemiparetic stroke, with detailed temporal assessments and multidimensional measures suggesting potential effects on both neural and non-neural components. However, given the single-center, open-label design, these findings should be interpreted with caution and validated in larger, controlled studies. Clinical Trial: jRCTs042240098

  • Healthcare provider-patient communication challenges: A scoping review protocol

    Date Submitted: Nov 24, 2025
    Open Peer Review Period: Nov 24, 2025 - Jan 19, 2026

    Background: Effective communication between healthcare providers (particularly physicians and nurses) and patients is crucial. However, numerous challenges exist across various care settings. This study aims to employ a scoping review methodology to identify the challenges in healthcare provider-patient communication, as well as the facilitating and inhibiting factors involved. Objective: This protocol aims to conduct a comprehensive scoping review to identify and analyze the challenges, barriers, and facilitators in healthcare provider-patient communication. The findings will inform the development of practical strategies and educational interventions to enhance the quality of care and patient satisfaction. Methods: This scoping review will be conducted following the Joanna Briggs Institute (JBI) methodology for scoping reviews. It will focus on research concerning communication between healthcare providers (including physicians, nurses, and clinical specialists) and patients. A comprehensive search strategy will be implemented using keywords such as "physician," "healthcare provider," "healthcare worker," "healthcare personnel," "healthcare professional," "patient," "client," "communication," and "communication skills." The search will be performed in two major databases, PubMed and Embase, for studies published between January 2000 and June 2023. There will be no restrictions on publication type or study design, and both quantitative and qualitative studies will be included. Participants in the selected studies will include healthcare providers and professionals with direct patient contact, as well as the patients themselves. For quantitative studies, appropriate checklists will be used depending on their methodology. The SRQR (Standards for Reporting Qualitative Research) checklist will be utilized for the quality assessment of qualitative studies. Results: This scoping review will synthesize and map the available evidence against the predefined objectives. The findings will be presented graphically and in a summary table, encompassing study characteristics, key themes related to challenges and facilitators, as well as communication outcomes. Conclusions: This article presents the protocol for a study that will identify communication challenges between healthcare providers, including nurses and physicians, and their patients. The findings of this research can assist health policymakers in planning strategies to enhance communication and improve the quality of healthcare services.

  • Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits, repetitive behaviors, and cognitive impairment. Side effects and inconsistent efficacy often limit current interventions such as pharmacological treatments and behavioral therapies. Massage therapy—including Tuina, acupressure, and other manual techniques—has been used as a non-pharmacological, low-risk complementary approach to improve cognitive symptoms in ASD, yet its overall efficacy and safety have not been systematically evaluated. Objective: This systematic review and meta-analysis aims to evaluate the efficacy and safety of massage therapy for improving cognitive impairment in individuals with ASD. Methods: Randomized controlled trials (RCTs) will be identified through searches of PubMed, Web of Science, Scopus, Cochrane Library, Embase, ClinicalTrials.gov, the Chinese Clinical Trial Registry, CNKI, Wanfang, VIP, and CBM until September 2025. Two reviewers will independently perform study selection, data extraction, and risk of bias assessment. For data synthesis, mean differences (MD) or standardized mean differences (SMD) will be used for continuous outcomes (e.g., ABC, CARS, ATEC scores), and odds ratios (OR) will be used for dichotomous outcomes (e.g., clinical efficacy rates). A random-effects model will be applied if the I²≥ 50%; otherwise, a fixed-effects model will be used. Subgroup, sensitivity, and meta-regression analyses will be performed to explore heterogeneity. The GRADE approach will be used to assess the quality of evidence. Results: This review will summarize evidence on the effect of manual therapy on cognitive outcomes measured by scales such as ABC, CARS, and ATEC, as well as safety profiles. Conclusions: The findings will provide evidence regarding the role of massage therapy in managing cognitive impairment in ASD and support clinical decision-making. Clinical Trial: PROSPERO 2025 CRD420251038194

  • Elements of virtual navigators for health and social services: Protocol for a scoping review

    Date Submitted: Nov 20, 2025
    Open Peer Review Period: Nov 21, 2025 - Jan 16, 2026

    Background: Patient navigation is a critical component of health care delivery, facilitating connections with appropriate services. A new era of virtual navigators are being developed that can be accessed through the web or smartphone application. However, it is unknown what features make virtual navigators accessible and reliable. Objective: The objective of this scoping review is to understand the current landscape of existing virtual navigation systems. In this review we will determine the features of these systems and barriers to accessibility they’ve identified. Methods: This review will follow the guidelines for scoping reviews outlined by the Joanna Briggs Institute (JBI) methodology. A search strategy will be used to locate both published and unpublished literature. The databases to be searched include PubMed, PsycINFO (ProQuest), Cochrane Library, Web of Science Core Collection (Clarivate), Cumulative Index of Nursing and Allied Health Literature (EBSCO), ScienceDirect, IEEE Xplore, and ACM Digital Library. Articles will be screened, selected, and extracted by 2 independent members of the research team. Results will be presented in table format and accompanied by a narrative summary. Results: As of September 2025, the preliminary stages of the scoping review have been completed. We anticipate the full scoping review manuscript will be prepared for submission by February 2026. Conclusions: This review will synthesize the current literature of virtual navigation tools and recommendations systems that aim to connect users to the appropriate health care services. By identifying trends and gaps, this review will provide critical information for the development of new and innovative systems that can support healthcare and public health systems.

  • Background: Background: Sepsis is defined as a life-threatening condition caused by a dysregulated host immune response to infection, often resulting in organ dysfunction. The heterogeneous nature and clinical presentation, overlapping with other acute conditions, often leads to diagnostic delays of sepsis, and consequently, to unacceptably high morbidity and mortality levels. Objective: This scoping review aims to identify and synthesise studies that use electronic medical record (EMR) data to develop or validate artificial intelligence (AI)-based models for the early detection or prediction of sepsis. Methods: Peer-reviewed studies published between March 2016 and February 2024 that use EMR data to develop, test, or evaluate AI or machine learning models for predicting sepsis or septic shock will be included. Adult participants (>18) will be included with no restriction on geographical location in this study. This scoping review will be guided by the updated JBI (formerly Joanna Briggs Institute) methodology. The search strategy will include relevant keywords and MeSH terms related to sepsis, electronic health records, and machine learning. Major electronic databases, including MEDLINE, PUBMED, EMBASE, CINAHL, and Cochrane Database of Systematic Reviews/Central Register of Controlled Trials, will be searched. Titles, abstracts, and full texts will be screened by two reviewers independently, with discrepancies resolved by consensus. Results: We will use publicly available data. No primary data will be collected. Ethical approval will not be required. Conclusions: Results will be extracted into a full report to be submitted to a peer-reviewed scientific journal and disseminated to stakeholders and partners in appropriate formats.

  • Background: : The global burden of Human Immune Virus (HIV) continues to challenge health systems, particularly in low and middle-income countries (LMICs), prompting the adoption of innovative service delivery strategies such as Nurse-Initiated Management of Antiretroviral Therapy (NIMART). While NIMART has expanded access to life-saving antiretroviral therapy (ART) and enhanced the decentralization of HIV care, the psychobiological and social responses of the nurses implementing this strategy have been largely underexplored. NIMART-trained nurses often work in high-pressure environments, facing occupational stressors that may manifest as burnout, anxiety, emotional exhaustion, and social stigma. Objective: This scoping review aims to systematically map the extent, nature, and characteristics of the existing literature on the psychobiological and social responses of NIMART-trained nurses providing care to people living with HIV (PLHIV). Methods: The review will be conducted in accordance with the Joanna Briggs Institute (JBI) methodology for scoping reviews. The Population, Concept, Context (PCC) framework will guide the development of the review question. A comprehensive search strategy will be employed to search electronic databases (PubMed, SABINET, and Google Scholar) for empirical studies published between 2010 and 2025. All three authors will participate in the review process: two authors will independently screen titles and abstracts, while the remaining author will verify eligibility decisions. Differences will be resolved through discussions and consensus among all authors. Data will be analyzed using narrative synthesis and thematic mapping to identify patterns, knowledge gaps, and implications for future research, practice, and policy. Results: The review is expected to identify the scope, trends, and gaps in the literature on psychobiological and social responses among NIMART-trained nurses. The estimated outcomes will include a synthesis of existing evidence, identification of key stressors and coping mechanisms, and a thematic categorization of psychobiological and social responses that influence the well-being and care delivery of NIMART-trained nurses. Conclusions: This scoping review will provide an evidence-based understanding of the psychobiological and social responses of NIMART-trained nurses, highlighting implications for policy, practice, workforce support, and future research. The findings will contribute to the optimization of HIV service delivery by improving the well-being and retention of NIMART-trained nurses. Clinical Trial: Open Science Framework (OSF): doi:10.17605

  • Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant global health concerns, particularly prevalent in low- and middle-income countries (LMICs). In China, a significant number of international migrants from LMICs reside, many of whom are at high risk of HBV/HCV infection with few test utilization. Previous studies presented Pay-it-forward (PIF) strategy has proven effective in promoting sexually transmitted infections (STIs) test in various populations. This study aims to evaluate the effectiveness of a PIF intervention in promoting HBV/HCV testing among international migrants from LMICs in China. Objective: Aims to evaluate the impact of a pay-it-forward (PIF) intervention in promoting hepatitis B virus (HBV) and hepatitis C virus (HCV) testing among international migrants from low- and middle-income countries (LMICs) residing in China. Methods: A two-arm cluster randomized controlled trial will be conducted in Guangzhou, China. Participants will be recruited from a public hospital serving a large migrant community. Eligible participants will be randomly assigned to either the PIF intervention arm or the control arm in a 1:1 ratio. Participants in the intervention arm will receive free HBV/HCV tests donated by previous participants and will have the opportunity to donate to support future tests. The control arm will receive standard medical services with self-paid testing. The primary outcome is the proportion of participants tested for both HBV and HCV. Data will be collected through a self-administered questionnaire and hospital records, and analyzed using generalized estimating equations to account for clustering effects. Results: The data collection has been completed, and the information of 100 participants was included to the data analysis. Conclusions: This study is innovative in targeting international migrants from LMICs in China and employing the PIF strategy to promote HBV/HCV testing. The PIF intervention is expected to increase testing rates by addressing financial barriers and fostering a sense of community support. The findings will contribute to the understanding of HBV/HCV testing promotion among this understudied population, with potential implications for public health policy and practice. Clinical Trial: ChiCTR2400082560. Registered on 1st April 2024.

  • Sustainable and Accessible Fall Prevention Medical Device for Aged Health: Research Protocol

    Date Submitted: Nov 9, 2025
    Open Peer Review Period: Nov 10, 2025 - Jan 5, 2026

    Background: Aging is inherently linked to increased vulnerability to adverse events, with falls being a primary concern for public health. Falls are the leading cause of severe injury and death among individuals over 65 years, significantly impacting their health, quality of life, and mobility 1,2. This growing issue significantly burdens healthcare systems, requiring extensive resources for hospitalization, rehabilitation, and long-term care 3. These challenges require innovative solutions that can effectively mitigate falls risk and improve the safety, independence, and quality of life for older adults while also easing the strain on healthcare systems 4. Several factors increase the risk of falls in older adults, including aging, low muscle mass due to physical inactivity, smoking, alcohol consumption, and malnutrition 5,6. Comorbidities such as diabetes, hearing loss, cognitive decline, poor sleep, chronic pain, and depression further exacerbate falls risk, leading to frailty and mobility limitations 7. Additionally, many older individuals live alone, which increases the likelihood of delayed help after a fall 8. Declines in physical, cognitive, and sensory functions significantly raise fall risk, making it increasingly important to identify innovative solutions to prevent falls and promote healthy aging 9. As Professor Bernard Isaacs (1924-1995) remarked, "A child takes one year to acquire independent movement and ten years to acquire independent mobility. An older adult can lose both in a single day." This highlights the potentially fatal consequences of falls, which can severely compromise mobility and independence 2. Recent technological advancements have introduced valuable tools for geriatric healthcare, offering solutions that improve quality of life, promote autonomy, and optimize healthcare delivery for older individuals 10. Technologies such as wearable devices (smartwatches and health sensors), telemedicine, robotic assistance, and health management systems play a central role in monitoring vital signs, facilitating early detection of health issues, and enabling remote care 11,12 In addition, technologies for rehabilitation, such as exoskeletons and exercise applications, provide support for physical activity, aiding in the prevention of falls and enhancing recovery 13,14. Building on the advent of the Internet of Things and Artificial Intelligence, the spectrum of possible solutions and applications continues to grow, with increasing the potential to monitor and predict fall risk and to enhance rehabilitation procedures 15. Despite these advances, challenges remain, including the accessibility of technologies, their integration into existing care systems, and the need for personalized solutions 16. The lack of coordination among various technological platforms can reduce efficiency and complicate the interpretation of data, while cost and usability can limit access for many individuals 17. Moreover, ensuring that non-pharmacological interventions (e.g. exercise-based technology) are tailored to the unique needs of each individual is essential for long-term success 18. The search for innovative solutions in public health is driven by the growing challenges of the aging population, particularly in fall prevention, chronic disease management, and overall well-being 19. As life expectancy increases, the prevalence of debilitating conditions also rises, requiring sophisticated and personalized approaches 20. Innovations such as wearable devices and remote monitoring systems offer the potential to enhance care quality, by enabling more precise and effective interventions. However, their adoption depends on accessibility, economic feasibility, and ease of use—especially for older adults with varying levels of digital literacy 21. The effectiveness of these solutions must be rigorously validated through dedicated studies to ensure improved health outcomes and reduced long-term healthcare costs. Effective technologies can prevent unnecessary complications and hospitalizations, while personalized interventions, based on precise data and continuous monitoring, address the specific needs of each individual 20,22. Digital technologies can offer accessible, customized solutions that overcome the limitations of traditional approaches, promoting safer and healthier aging 23. Collaboration between healthcare professionals, developers, and final users' contributions may also be important to ensure that solutions are relevant, effective, and sustainable in the long term 24. Identifying and addressing limitations during the research and development process can reduce barriers to adoption and improve implementation, increasing the likelihood that fall prevention technologies will be successfully integrated into care strategies for the aging population 9. Given these challenges, there is a growing need for innovative and sustainable solutions that address the multifaceted nature of fall prevention. This study aims to lay the foundation for the development of a web-based medical device and app platform that integrates digital technologies, physical-functional assessments, and user-centered approaches to predict and prevent falls in older adults. Objective: To explore, evaluate, and establish the foundation for Stage 1 of the Sustainable and Accessible Fall-Prevention Medical Device Technologies for Older Adults’ Health (S@FHe-RP). Research Questions I. What digital medical device technologies are currently available for predicting fall risk in older adults, and how do they compare in terms of functionality, usability, and effectiveness? II. Which physical-functional assessments are commonly used to evaluate fall risk in older adults, and how can these be adapted or enhanced through medical device–based digital technologies? III. How do end users, including healthcare professionals and nursing home staff, perceive the acceptability, feasibility, and functionalities of fall-prevention medical devices? IV. Which bio-socio-demographic factors are essential for developing a reliable and accurate medical device–driven fall prediction model in long-term care facilities? V. How can the integration of multidisciplinary and technological approaches, including medical device innovation, overcome the limitations of current fall-prevention strategies and support the development of sustainable solutions in long-term care facilities? Methods: This research protocol is structured into four interconnected studies (Stage 1–Stage 4), each designed to systematically align the research process with the overarching objectives of the project. Stage 1 involves a scoping review (Study 1) to identify and map existing digital technologies used to predict fall risk in older adults. Stage 2 (Study 2) focuses on a comprehensive systematic review comparing traditional and technology-adapted physical fitness assessment tests. Stage 3 (Study 3) explores the development of a statistical prediction model based on bio-sociodemographic indicators to estimate fall risk. Finally, Stage 4 (Study 4) integrates the end-users’ perspectives—health professionals and caregivers in long-term care settings—to inform the design and implementation of a sustainable, user-centered fall-prevention technology. Together, these four stages create a cohesive framework that bridges evidence synthesis, model development, and practical application, ensuring scientific rigor and real-world relevance. The methodology follows recent approaches 25,26, integrating technological, clinical, and user-centered dimensions. Project Design A mixed-methods approach will be employed, comprising four complementary and consecutive studies to support the development of a low-cost, web-based app platform for fall prevention in older adults. This platform will comply with European medical device regulations, meeting validation criteria for medical devices 27. The research characterizes contemporary translational research, which involves effectively translating scientific knowledge into new health technologies 28. Furthermore, the development of this medical device will involve researchers from distinct areas of clinical, technological, and industrial sectors, following a User-Centered Design (UCD) approach 29. Figure 1. Module A: Scoping review of new digital technologies to predict falls This phase involves a systematic scoping review of the literature across relevant databases, specialized journals, and grey literature, aiming to analyze studies examining new digital thecnologies used to predict fall risk in older adults. This study will adhere to established methodological guidelines, including the exploratory review framework by Arksey and O'Malley (as refined by 30), and the Joanna Briggs Institute (JBI) guidelines 31. Results will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines 32. A reproducible four-step search strategy, as recommended by JBI 33, will be implemented across databases (see Table 1): Medline, Web of Science, SCOPUS, Cochrane Library, B-On, CINAHL, PsycINFO, Google Scholar, and Open Access Thesis and Dissertations. The search terms included: ((Falls prevention) OR (Fall risk)) AND (Elderly) AND (Digital technologies) AND (Long-term care)). The inclusion criteria, guided by the Joana Brigs framework 34, will include studies involving older adults (≥60 years) (Population), examining technological devices assessing fall risks related to gait performance (Concept), across various settings, countries, and sectors of the economy (Context). Two reviewers will design the strategy, which will be reviewed by a third expert using the PRESS checklist 35. Selection criteria will include original research, systematic reviews, theses, grey literature, patents and prototypes from the last ten years. Quantitative studies (randomized controlled trials, non-randomized trials, quasi-experimental studies) and observational studies (descriptive, exploratory, and analytical designs) will be considered. The initial search will be conducted in English, and may be expanded to include Spanish and Portuguese depending on preliminary findings. Findings will summarize studies by PCC, answer research questions, and describe study characteristics. Module B: Review of Traditional and Tech-Adapted Physical Fitness Tests This comprehensive review will identify traditional and technology-adapted physical-functional tests (PFT) for fall risk assessment in older adults. The review will focus on the effectiveness, ease of use, accuracy, and implementation challenges. A systematic search across multiple databases (Medline via PubMed, Scopus, Web of Science, CINAHL) will target studies from the last decade using terms such as “fall risk assessment,” “functional test,” “older adults,” “physical test,” “digital adaptations,” and “technology for fall prevention.” Inclusion criteria include original research, systematic reviews, and relevant grey literature. Results will follow PRISMA guidelines 36, Cochrane guidelines for systematic reviews, and the GRADE methodology for evaluating the quality of evidence 37. The PICO framework 38 will structure reporting: Population (≥ 60 years, including clinical subpopulations), Intervention (traditional and adapted PFTs), Comparison (traditional vs. digital/technological adaptations), and Outcome (effectiveness on fall risk assessment). Module C: Fall risk prediction statistical model This cross-sectional study is aimed to develop a predictive algorithm for fall risk based on bio-socio-demographic indicators. This study will involve approximately 300 institutionalized older adults from Coimbra, Portugal, levering data from the PRO-HMESCI project 39 project. Participants will provided informed consent, with ethical approval obtained from the Faculty of Sports Sciences and Physical Education Ethical Committee, University of Coimbra (code number: CE/FECDEFUC/0002013, CE/FCDEF-UC/00112024). Collected data includes sociodemographic data (age, marital status, education), anthropometric measures (weight, height, BMI), cognitive status 40, state of depression 41, comorbidity index 42, functional fitness (e.g. upper and lower body muscle strength and balance), and falls history. Advanced statistical techniques will be applied to identify significant patterns and relationships between bio-socio-demographic indicators and risk of falls in older adults. Bivariate analysis methods, such as the chi-square test and Pearson's correlation coefficient, will be used to explore associations between categorical and continuous variables. Multivariate logistic regression will be applied to identify the most significant factors contributing to fall risk 43 and construct the predictive model. Model validation will be performed using cross-validation techniques and Receiver Operating Characteristic (ROC) curve analysis to assess the accuracy and predictive power of the algorithm 44. Module D: End-Users' Perspective study The objective of this study is to validate the necessity, feasibility, and acceptance of a technology-based fall prevention product by healthcare professionals working in long-term care facilities. This study will adopt a mixed-methods approach, combining qualitative and quantitative techniques to evaluate the acceptance and perceived utility of a new technology-based solution for fall prevention in older persons in care facilities. It seeks to understand user perspectives, barriers, and facilitators, as well as institutional specificities related to long-term care, based on the UCD methodology 45. The adapted Technology Acceptance Model (TAM) serves as the theoretical framework connecting the study's qualitative and quantitative assessement 46. Insights gathered through qualitative interviews will inform the contextual understanding of perceived usefulness, ease of use, and behavioral intention, which are central to the TAM framework 46. These constructs guide the design and evaluation of fall prevention technologies, as visualized in Figure 2, ensuring alignment with user needs and practical applications. Participants include higher-education healthcare professionals (nurses, physicians, physiotherapists, gerontologists) with at least one year experience in long-term care. For the qualitative phase, theoretical saturation is expected to occur after 15–20 interviews, following similar previous studies 47. For the quantitative phase, the sample size will be calculated using G*Power, based on the sample size as shown in previous studies 48. Qualitative analysis will employ thematic content analysis using NVivo® 49; quantitative analysis will employ TAM-based questionnaire to evaluate variables such as perceived usefulness (10 items), perceived ease of use (11 items), behavioral intention (4 items), and demographic data (6 items) 50. Data collection will occur via online and in-person distribution, with follow-up to ensure response completeness. Descriptive and inferential statistical analyses will be conducted using SPSS. Ethical Procedures The research protocol was approved by the same committee under the project number CE/FCDEF-UC/00112024, which ensures compliance with ethical standards for research involving human participants. Procedures will comply with the European Union directives 51, and relevant guidelines from the International Organization for Standardization 52. Clinical studies will also adhere to the ethical principles outlined in the Declaration of Helsinki and the guidelines for Good Clinical Practice 53. As we are currently in Stage 1 of the project, the Portuguese regulatory body responsible for overseeing the evaluation authorization, and monitoring of medicines, medical devices, and health products in Portugal 54 approval is not required at this point, but it will be necessary in Stage 2 when developing and validating the platform prototype. Results: The study aims to significantly advance fall risk prevention by integrating traditional and technological approaches. A key outcome will be a comprehensive analysis of PFTs, both conventional and technology-adapted, to identify the most effective methods for assessing fall risk. By systematically comparing these approaches, the study will bridge the gap between traditional clinical assessments and emerging technologies 55, providing a roadmap for integrating innovative tools into routine practices and highlighting their complementary potential. Additionally, the study will support the development and preliminary validation of low-cost, data-driven algorithm to predict fall risk in older adults. By combining bio-sociodemographic, clinical, and functional data, this tool will enhance clinical decision-making and enable timely , targeted interventions 56, with a strong emphasis on early screening and fall prevention 57. The evaluation of existing fall risk assessment technologies will also play a central role, aiming to verify their reliability and accuracy. This assessment will help to identify strengths and limitations, guide future development, and establish benchmarks for next-generation tools. A particular focus on gait performance and fall risk will contribute to ongoing advancements in smart wearable devices and motion analysis technologies 14. Moreover, the study will capture end-user perspectives, particularly from healthcare professionals working in long-term care facilities. It will explore factors influencing the adoption of fall prevention technologies, including barriers, facilitators, and overall acceptability. Applying the UCD approach will ensure that future solutions align with the real-world needs and preferences of those who use them 58. Finally, this work will establish a solid foundation for developing a web-based medical device for fall-risk management. Following evidence generation and ethical ethical approval, the next phase will involve rigorous prototype testing to ensure safety, efficacy, and compliance with international standards, including EU and ISO guidelines 51. Conclusions: The research protocol aims to provide valuable insights into the development and adoption of fall prevention technologies for older adults using a user-centered design approach. By focusing on low-cost, sustainable, and accessible solutions, the study addresses the pressing need for equitable healthcare innovations—particularly in underserved and resource-limited contexts. The findings will contribute to enhancing fall prevention strategies and ensuring that future technologies are not only clinically effective but also aligned with real-world needs and preferences of their users.

  • Background: Shifting surgeries from the stationary to the ambulatory setting is seen as a suitable way of increasing efficiency in the health care system. A significant increase in ambulatory procedures can therefore be observed internationally – particularly in the field of orthopedics. However, the interests and needs of patients are often insufficiently taken into account in this process. The "Power-AOP" research project was initiated to identify the associated challenges in the area of patient empowerment and to develop solutions. Using the field of orthopedics as an example, it investigates how the self-determination and participation of patients can be strengthened in the context of ambulatory surgery. Methods: Using a mixed methods approach, (health policy) recommendations will be developed that aim to strengthen patient empowerment in the context of ambulatory surgery. The project is scheduled to run for three years and comprises six work packages with a total of ten modules. In a first step, a scoping review will be carried out to map the existing literature. This will be followed by focus groups with patients and healthcare providers to gain deeper insights into their experiences and perspectives. The results will be quantified through a questionnaire-based survey. In order to identify a suitable patient population for this survey, an analysis of claims data will be conducted beforehand. The results will then be discussed and refined in two stakeholder workshops with key players in the health care system. In the final phase, a concept will be developed that contains actionable recommendations for strengthening patient responsibility in the context of ambulatory care. Discussion: This project will help to improve the patient empowerment in the context of ambulatory surgery. This allows patients to take a more active role in the process. On the one hand, this can lead to greater satisfaction with the process, particularly among patients. On the other hand, more active participation by patients can improve outcomes and avoid unnecessary readmissions or additional treatments.